In a 48‑year‑old chronic alcoholic with AST markedly higher than ALT, elevated alkaline phosphatase and bilirubin, is this intrahepatic cholestasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intrahepatic Cholestasis in Chronic Alcoholic Liver Disease

Yes, this clinical presentation is consistent with intrahepatic cholestasis secondary to alcoholic liver disease, specifically alcoholic hepatitis with severe cholestatic features.

Diagnostic Reasoning

The combination of chronic alcoholism, AST markedly exceeding ALT (typically AST/ALT ratio >2), elevated alkaline phosphatase, and elevated bilirubin strongly suggests alcoholic hepatitis with intrahepatic cholestasis rather than extrahepatic biliary obstruction 1.

Key Biochemical Pattern

  • AST/ALT ratio >2 is characteristic of alcoholic liver disease, with approximately 70% of patients demonstrating this pattern 1, 2.
  • In alcoholic hepatitis, the AST/ALT ratio typically exceeds 1.5 in over 98% of histologically confirmed cases 1, 2.
  • Both transaminases rarely exceed 300-400 IU/mL in alcoholic liver disease, distinguishing it from acute viral hepatitis or drug-induced injury 1, 2.

Cholestatic Component

Intrahepatic cholestasis occurs frequently in alcoholic liver disease and is often secondary to alcoholic hepatitis rather than fatty liver alone 3. The histologic hallmarks include 1:

  • Periportal ductular proliferation
  • Ductular bilirubinostasis
  • Intraparenchymal cholestasis (bile accumulation within hepatocytes and canaliculi)
  • Severe inflammation with neutrophil infiltration

In patients with alcoholic liver disease presenting with marked alkaline phosphatase elevation (>4× upper limit of normal), significantly more hepatocellular necrosis, alcoholic hyaline, and cholestasis are observed histologically compared to those with normal or mildly elevated alkaline phosphatase 3.

Distinguishing Intrahepatic from Extrahepatic Cholestasis

The AST/ALT ratio is diagnostically valuable: In alcoholic chronic pancreatitis with cholestasis, an AST/ALT ratio ≥1.5 typically indicates intrahepatic cholestasis, while a ratio ≤1.4 suggests extrahepatic obstruction requiring surgical evaluation 4.

Clinical Significance

  • Severe intra-parenchymal cholestasis in alcoholic steatohepatitis is an independent predictor of short-term mortality, along with Maddrey's discriminant function score 1.
  • "Secondary intrahepatic cholestasis" can occur in the natural course of chronic liver diseases and may denote severe disease progression toward end-stage liver disease 5.
  • Microscopic cholangitis (intraductal polymorphonuclear leukocytes) represents a feature of severe cholestasis in alcoholic liver injury and correlates with markedly elevated bilirubin, alkaline phosphatase, and cholesterol 6.

Diagnostic Workup

Imaging is essential to exclude extrahepatic obstruction 1:

  • Abdominal ultrasound as first-line imaging to assess for dilated bile ducts, gallstones, or masses 7.
  • If ultrasound is negative but clinical suspicion remains, proceed to MRI with MRCP, which is superior for detecting biliary abnormalities 7.

Liver biopsy should be considered in patients with severe alcoholic hepatitis requiring corticosteroid treatment, both for definitive diagnosis and prognostic assessment 1, 2. Histologic findings confirming intrahepatic cholestasis include 1, 8:

  • Ductular bilirubinostasis
  • Intraparenchymal cholestasis (bile plugs in canaliculi)
  • Ballooning degeneration with Mallory-Denk bodies
  • Neutrophil infiltration and megamitochondria

Critical Pitfalls to Avoid

  • Do not assume extrahepatic obstruction based solely on elevated alkaline phosphatase—intrahepatic cholestasis from alcoholic hepatitis can produce marked elevations (>4× ULN) without biliary obstruction 3.
  • Do not overlook the AST/ALT ratio—a ratio >2 strongly favors alcoholic etiology over other causes 1, 2.
  • Do not delay imaging—even with a classic biochemical pattern, extrahepatic obstruction must be excluded by ultrasound or MRCP 1, 7.
  • Recognize that cholestatic patterns in alcoholic liver disease may mimic extrahepatic obstruction biochemically, but the AST/ALT ratio and clinical context guide differentiation 6, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Alcohol-Related Liver Disease and Thrombocytopenia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Intrahepatic cholestasis in common chronic liver diseases.

European journal of clinical investigation, 2013

Guideline

Causes of Chronic Alkaline Phosphatase (ALP) Elevation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Steatosis and Cholestasis: Key Differences and Diagnostic Approaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis and management for a patient with elevated liver enzymes (aspartate aminotransferase (AST) 66, alanine aminotransferase (ALT) 77), normal total bilirubin (0.4), and slightly elevated alkaline phosphatase (72)?
What is the implication of having elevated liver enzymes (ALT 141, GGT 141, AST 37, ALP 109)?
Should I be concerned about elevated liver enzymes with Alanine Transaminase (ALT) of 56 and Aspartate Transaminase (AST) of 49?
What is the significance of elevated liver enzymes, ALT 76 and AST 44, in an adult patient?
What is the likely diagnosis and initial management for a 48‑year‑old chronic alcoholic presenting with markedly elevated alkaline phosphatase, moderately increased aspartate aminotransferase, relatively low alanine aminotransferase, and total bilirubin of 7 mg/dL?
What is an appropriate sleep aid for an elderly patient, considering safety and comorbidities such as dementia, chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and renal or hepatic impairment?
In a 4-year-old boy weighing 19 kg with a one-day history of painful, edematous tongue and swollen papillae without fever, what is the appropriate initial management?
For a hemodynamically stable patient with a ventricular rate of 140 beats per minute and no contraindications to beta‑blockers, what is the recommended initial metoprolol dosing and rate‑control strategy?
Patient with cardiac history and tachycardia (140 bpm) not on any medications—should I start metoprolol (beta‑blocker)?
Is arrowroot flour beneficial for gut health?
Which severity scoring systems are recommended for acute pancreatitis and how should they be applied to guide management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.